Investor Presentaiton
MEDIFOX DAN snapshot
^ ^ ^ ^
At a glance
Leading software provider within growing German
healthcare sector supported by structural growth drivers
End-to-end solution and the operating system of choice
used daily by 300K+ caregivers
Mission-critical technology deeply embedded in
workflows within a large, growing and highly loyal
customer base
High-caliber and experienced management team with a
proven track record of delivering profitable growth
$83M
PF Revenue (1,2)
(CY 2021)
By the numbers
$35M
PF Adj. EBITDA(1,2)
(CY 2021)
14%
Organic Revenue CAGR(2)
(CY19 - CY21)
8K+
Customers
300K+
600
Caregivers that use
platform daily
Employees
1. Based on a EUR/USD rate of 1.053.
2. Pro forma adjusted for acquisitions.
52022 ResMed. Company confidential.View entire presentation